Introduction {#sec1-1}
============

As of January 2011, Peruvian migrants represent the largest Latin American community in Italy with 101,711 documented residents accounting for 2.9% of migrant population, corresponding to about 30% of Latin Americans in Italy.^[@ref1]^ The number of Peruvian citizens in Italy has increased 30 folds since the early nineties. The majority of them are young-adults (70% aged between 18 and 49 years) and the female gender is slightly prevalent (61%). The large majority (70%) are currently concentrated in few large metropolitan areas namely Milan (33,919 documented residents), Rome (15,262), Turin (10,872), Florence (7834) and Genoa (3277).^[@ref1]^ In 2009 (the last year with official surveillance data available), 48.3% (2053) of tuberculosis (TB) cases in Italy were diagnosed in foreign born subjects, with Peruvians accounting for 5% of them (103 cases).^[@ref2]^ In the health district of Florence (Azienda Sanitaria Locale, ASL 10), the number of reported TB cases remained almost stable in the last 10 years with around 100-130 cases per year and an incidence of 10-14 cases per 100,000 populations.^[@ref3]^ Nevertheless, in the same period, the number and the proportion of Peruvian subjects diagnosed with TB in Florence has steadily increased. Starting from 2005, Peruvians represent the foreign community with highest TB burden in Florence, accounting for about 20% of cases (22 out of 110 in 2009 and 25 out of 133 in 2010).^[@ref3],[@ref4]^

The findings of a retrospective study aiming to understand the epidemiological dynamics of TB transmission in the Peruvian community of Florence are reported here.

Materials and Methods {#sec1-2}
=====================

Main epidemiological and clinical features of TB cases notified in Peruvian citizens resident in the ASL 10, in the period 2001-2010 were retrospectively collected from the databases of *UF Igiene e Sanità Pubblica, ASL 10 Zona Firenze*, Florence, Italy and *SOD Microbiologia e Virologia, Centro di Riferimento per i Micobatteri della Regione Toscana, Azienda Ospedaliero Universitaria Careggi,* Florence, Italy. Incidence of TB in the Peruvian community of Florence was estimated on the basis of number of TB cases notified each year in the ASL 10 (used as numerator) and number of documented Peruvian residents in the province of Florence (used as denominator).^[@ref5]^ Available *Mycobacterium tuberculosis* strains isolated were characterized by genotyping analysis with Mycobacterial Interspersed Repetitive Units - Variable Number Tandem Repeat (MIRU-VNTR-24) and Spacer Oligonucleotide Typing (Spoligotyping).^[@ref6],[@ref7]^ Clonally related strains were defined as clustered and assumed to belong to a chain of recent transmission, while patients whose *M. tuberculosis* isolate did not present a shared pattern were assumed to originate from reactivation of a latent tuberculosis infection (LTBI).^[@ref8]^ As this was a retrospective study on routinely collected surveillance data and on samples collected at the Regional TB reference laboratory, ethical approval was not deemed necessary.

Results {#sec1-3}
=======

One hundred and thirty-eight TB cases were retrieved. Among them, 119 (86%) were microbiologically confirmed. The number of reported cases steadily increased through the years, from 11 (8%) in 2001-2002 to 47 (34.1%) in 2009-2010. The estimated incidence rates varied, in the considered period, from 484 and 351 per 100,000 Peruvian residents in Florence. Main epidemiological and clinical features of TB cases are summarized in [Table 1](#table001){ref-type="table"}.

Eighty-seven *M. tuberculosis* strains were available for genotyping analysis ([Figure 1](#fig001){ref-type="fig"}).

MIRU-VNTR-24 analysis showed 48 strains (55.2%) displaying a non-shared genotype, which were interpreted as originating from LTBI reactivation. Thirty nine (44.8%) *M. tuberculosis* strains showed a genotype shared at least by another strain, fulfilling the definition of clustered cases. Three clusters included 2 subjects, 3 clusters included 3 subjects, 4 clusters included 4 subjects and 1 cluster included 6 subjects. In the majority of clusters (10 out of 12) the time elapsed between the diagnosis of the first and the last case was shorter than five years. Spoligotyping showed that the lineages circulating in the community were Haarlem (n=31, 35.6%, 14 clustered and 17 non-clustered), Latin American-Mediterranean (LAM, n=28, 32.1%, 12 clustered and 16 non-clustered), T-specific (n=8, 9.2%, 2 clustered and 6 non-clustered) Beijing (n=5, 5.7%, 4 clustered and 1 non-clustered), Ural (n=3, 3.4%, all clustered), S (n=1, 1.1%). Eleven (12.6%, 4 clustered and 7 non-clustered) previously unreported spoligotypes (orphans) were also present.

Discussion and Conclusions {#sec1-4}
==========================

The study shows that TB in the Peruvian community in Florence is a concerning problem considering its high estimated incidence. In 2009, the last year for which final data are available at national level, the estimated incidence of TB in Peruvian born in Italy (117 per 100,000) was very similar to the one reported for Peruvian residents in Peru (113 per 100,000) and much lower if compared with that found in this study (381 per 100,000).^[@ref9]^ Supported by the finding of a high rate of clustered cases, we can affirm that the higher TB incidence in Peruvian residents in Florence (3.2 time higher compared with incidence in the country of origin) is related to an ongoing active transmission within the community. In the matter of facts, excluding one case for each cluster that should be considered the *index case*, the remaining clustered cases are due to recent infections occurred in Florence.

A limitation of this study is that we considered in the analysis only *M. tuberculosis* strains isolated from Peruvian individuals living in Florence. This greatly limit the possibility of inferring the origin of active TB (new infection *vs* reactivation) from cluster data. In other word, if a Peruvian patients is not in a cluster with other Peruvian patients, it is not possible to rule out that this patients was not part of a cluster in which the index case was a non-Peruvian patient living in the same area, and thus to infer that TB in that patient was due to reactivation of a remotely acquired infection. Thus the number of patients in cluster should be regarded as a minimum estimate of cases due to recent infection. Peruvian origin has been previously identified as risk factors for TB clustering in a previous Italian study carried out in Milan.^[@ref10]^ Another study conducted in the late nineties in Milan evidence a 1.6 time higher TB incidence in Peruvian migrants compared with TB incidence in Peru.^[@ref10]^ Considering data obtained in the studies carried out in Milan and in Florence, Peruvian migrant communities of both cities emerge as a vulnerable group which may benefit from targeted intervention and TB control activities. Strengthening of preventive intervention, such as early diagnosis of active TB cases and contact tracing procedures, should be prioritized for this population. An easy access to TB services for the members of this communities should be assured, regardless of legal status of subjects. Collaboration between different partners such as public health services, primary care physicians, tertiary hospitals and non-for profit sector is warranted to achieve a timely diagnosis of TB and to ensure case holding of affected subjects. Socially and culturally acceptable education programs on TB with a multidisciplinary approach should be reinforced.
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###### 

Clinical, microbiological and epidemiological features of tuberculosis cases notified in Peruvian citizens resident in the Health District of Florence, Italy, in the period 2001-2010.

                                                                           Cases with genotyping available (87)   All cases[\*](#tfn001){ref-type="table-fn"}                   
  ------------------------------------------------------------------------ -------------------------------------- --------------------------------------------- --------------- -----------------
  Male/female ratio                                                        0.6                                    0.8                                           0.4             0.7
  Age ≤15 years                                                            9/87 (10.3%)                           6/39 (15.3%)                                  3/48 (6.2%)     15/138 (10.9%)
  Age 16-50 years                                                          77/87 (88.5%)                          33/39 (84.6%)                                 44/48 (91.7%)   120/138 (86.9%)
  Age \>50 years                                                           1/87 (1.1%)                            0/39 (0%)                                     1/48 (2.1%)     3/138 (2.2%)
  Diagnosis of tuberculosis within 5 years from arrival in Italy           52/83 (62.6%)                          20/32 (62.5%)                                 32/48 (66.7%)   81/116 (69.8%)
  Diagnostic delay \>60 days                                               32/72 (44.4%)                          12/32 (37.5%)                                 20/40 (50%)     46/113 (40.7%)
  Pulmonary localization only                                              68/86 (79.1%)                          32/38 (84.2%)                                 36/48 (75%)     106/136 (77.9%)
  Pulmonary and extrapulmonary localization                                5/86 (5.8%)                            3/38 (7.9%)                                   2/48 (4.2%)     8/136 (5.9%)
  Extrapulmonary localization only                                         12/86 (13.9%)                          3/38 (7.9%)                                   9/48 (18.7%)    20/136 (14.7%)
  Disseminated tuberculosis                                                1/86 (1.2%)                            0/38 (0%)                                     1/48 (2.1%)     2/136 (1.5%)
  Smear positive tuberculosis among subjects with pulmonary localization   43/73 (58.9%)                          19/35 (54.3%)                                 24/38 (63.1%)   60/114 (52.6%)
  HIV prevalence                                                           1/47 (2.1%)                            0/25 (0%)                                     1/27 (3.7%)     2/73 (2.7%)
  Pan-susceptible strains                                                  75/84 (89.3%)                          37/38 (97.4%)                                 38/46 (82.6%)   93/113 (83.3%)
  Multi drug resistant strains                                             2/84 (2.4%)                            0/39 (0%)                                     2/46 (4.3%)     9/113 (8%)

\*Includes all tuberculosis cases notified in Peruvian citizens resident in the ASL 10 (Florence, Italy), in the period 2001-2010 regardless of the availability of the genotyping analysis.
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